Announcements Trials
Browse Landscape

Phase

Phase 2 131Phase 1 42Phase 3 27Phase 1/2 27Phase NA 8Phase 2/3 6Phase 4 4Phase EARLY_PHASE1 1

Status

Recruiting 2Not yet recruiting 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 4Sarcoma 2CNS 1

Conditions

Sarcoma, Ewing 1Recurrence 1Glioblastoma 1Gastrointestinal Stromal Tumors 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Asian Colorectal Cancer Patients 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20Vincristine 18venetoclax 17apatinib 17Rituximab 17Prednisone 17Letrozole 17Irinotecan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2/3 × regorafenib × Clear all
NCT03970447 2026-05-15

GBM AGILE

Global Coalition for Adaptive Research

Phase 2/3 Recruiting
2,250 enrolled
CNS

Glioblastoma, Recurrence

NCT07379047 2026-04-24

GISTAR-1

Ningbo Newbay Technology Development Co., Ltd

Phase 2/3 Not yet recruiting
255 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT06820957 2026-02-17

Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body

Children's Oncology Group

Phase 2/3 Active not recruiting
437 enrolled
Sarcoma

Sarcoma, Ewing

NCT07392866 2026-02-09

A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma

Nanjing Sanhome Pharmaceutical, Co., Ltd.

Phase 2/3 Not yet recruiting
120 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05462613 2024-12-20

REPROGRAM-02

Centre Hospitalier Universitaire de Besancon

Phase 2/3 Recruiting
446 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01189903 2014-01-28

Clinical Evaluation - A Phase IIA Proof of Concept Study of Regorafenib (Bayer 73-4506) in Biopsy-amenable Asian Colorectal Cancer Patients

National University Hospital, Singapore

Phase 2/3 Unknown
Gastrointestinal

Asian Colorectal Cancer Patients

Data powered by HemOnc (CC BY 4.0) Colophon âš¡